Navigation Links
Discovery of new gene associated with diabetes risk suggests link with body clock

A connection between the body clock and abnormalities in metabolism and diabetes has been suggested in new research by an international team involving the University of Oxford, the Wellcome Trust Sanger Institute and the MRC Epidemiology Unit in Cambridge.

The researchers have identified a gene involved in the way the body responds to the 24 hour day-night cycle that is strongly linked to high blood sugar levels and an increased risk of type 2 diabetes. The results of the genome-wide association scan are published in Nature Genetics.

"We have extremely strong, incontrovertible evidence that the gene encoding melatonin receptor 1B is associated with high fasting glucose levels and increased risk of type 2 diabetes," says Professor Mark McCarthy of the Oxford Centre for Diabetes, Endocrinology and Metabolism at the University of Oxford.

Melatonin is a hormone that is strongly tied to control of our sleep-wake cycles, with concentrations in the blood peaking at night-time and dipping during the day. As a result, melatonin is implicated in conditions like jetlag and sleep disorders.

Disrupted sleep patterns are known to be associated with a range of health problems including metabolic disorders like diabetes, but it is not understood how they are connected. In identifying a link between a melatonin receptor and blood sugar levels, this study provides genetic evidence that mechanisms controlled by our body clock are connected to the machinery that keeps us metabolically healthy. It seems likely that the action of melatonin on the pancreas is being disturbed in this case, the researchers suggest.

The international research collaboration combined ten genome-wide association scans involving a total of over 36,000 individuals of European descent. A variant in the gene encoding melatonin receptor 1B (MTNR1B) showed a rise of 0.07 mmol/l in fasting glucose level on average and a 9% increase in risk of type 2 diabetes for each copy of the gene variant inherited from a parent.

"High fasting glucose levels are early markers of diabetes and this observation provides important clues about the possible mechanisms linking genes to diabetes risk," says Professor Nick Wareham, Director of the MRC Epidemiology Unit in Cambridge.

Other genes have previously been shown to be associated with high blood sugar levels, but have not shown an increase in diabetes risk. The melatonin receptor found in this genome-wide study is the first gene to be linked to both high blood sugar and increased risk of diabetes.

"Although levels of glucose in the blood are used to diagnose diabetes, most of the genes previously associated with high glucose levels do not increase risk of diabetes," says Dr Ins Barroso from the Wellcome Trust Sanger Institute. "We have found a variant - a G in the genome in place of a C - in MTNR1B. This single-letter change influences both sugar levels and diabetes. This remarkable result should allow us to gain new insight into this problem."


Contact: Jonathan Wood
Wellcome Trust Sanger Institute

Related biology news :

1. Kidney function discovery sheds light on genetic complexity of disease
2. New discovery may enhance MRI scans, lead to portable MRI machines
3. Discovery of giant roaming deep sea protist provides new perspective on animal evolution
4. New $11 million center to speed production of new compounds for drug discovery
5. FSU researchers discovery leads to $1.5 million grant, potential new treatment of liver fibrosis
6. Nanoscopic screening process to speed drug discovery
7. Discovery of natural compounds that could slow blood vessel growth
8. Groundbreaking discovery may lead to stronger antibiotics
9. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
10. Chemical equator discovery will aid pollution mapping
11. Life Sciences Discovery Fund advances latest research proposals
Post Your Comments:
(Date:11/19/2015)... MOUNTAIN VIEW, Calif. , Nov. 19, 2015 /PRNewswire/ ... authentication market, Frost & Sullivan recognizes BIO-key with the ... Strategy Leadership. Each year, Frost & Sullivan presents this ... comprehensive product line catering to the needs of the ... which the product line meets and expands on customer ...
(Date:11/17/2015)... 2015 Paris from 17 ... Paris from 17 th until 19 ... innovation leader, has invented the first combined scanner in the ... same scanning surface. Until now two different scanners were required: one ... capture both on the same surface. This innovation is ...
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
Breaking Biology News(10 mins):
(Date:11/23/2015)... Calif., Nov. 23, 2015   Ceres, Inc . ... today financial results for the fiscal year ended August ... --> --> During ... forage and feed products with a better balance of ... signed distribution agreements with several leading crop input providers ...
(Date:11/23/2015)... ... November 23, 2015 , ... Shimadzu ... of its Nexera UC Unified Chromatography system. The award from R&D magazine recognizes ... products of the year in the analytical and testing category. R&D Magazine chose ...
(Date:11/23/2015)... 2015 The royalty-free a ... to develop daclatasvir for 112 low- and m ... --> --> The Medicines Patent Pool ... medicine, signing an agreement with Bristol-Myers Squibb for daclatasvir, a ... genotypes of the HCV virus.  The royalty-free licence will enable ...
(Date:11/23/2015)... 23, 2015 biochar market ... 2015, and it is expected to grow with a ... driving the growth of the global market include improved ... of biochar, increased government initiatives and stringent environmental regulations, ... stringent environment regulations are the key drivers for the ...
Breaking Biology Technology: